UK says home-grown cancer pill too costly to use

LONDON (Reuters) – Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research centre, a decision critics said was bad for patients and research. If the draft ruling is upheld after further consultation, Zytiga, which is marketed by Johnson & Johnson, will not be reimbursed on the state-run …

Government says home-grown cancer pill too costly to use

LONDON (Reuters) – Britain's health cost watchdog NICE sparked a major row on Thursday by snubbing a pricey new prostate cancer pill discovered at the country's top cancer research centre, a decision critics said was bad for patients and research. If the draft ruling is upheld after further consultation, Zytiga, which is marketed by Johnson & Johnson, will not be reimbursed on the state-run …

PVH Corp. and The V Foundation for Cancer Research Announce New Neckwear Line Benefiting Cancer Research

PVH Corp. , one of the world’s largest apparel companies, and The V Foundation for Cancer Research, one of the nation’s leading cancer research fundraising organizations, announced a new partnership to offer The V Foundation Neckwear Collection – a line of ties inspired by memorable current and past sports figures.

Cancer campaigners say levels of fat, salt and sugar in food must be reduced

Health researchers claim maintaining healthy lifestyle and eating well could prevent as many as a third of all cancers Foodstuffs and drinks need to contain less sugar, salt and fat in order to help combat the growing number of people developing cancer, campaigners against the disease have said. The call from the World Cancer Research Fund (WCRF) came as it released fresh estimates that the …

Research and Markets: Cancer Therapies – Global Strategic Business Report: Immunotherapy, Targeted Therapy, Hormonal …

Research and Markets has announced the addition of the "Cancer Therapies – Global Strategic Business Report" re

Research and Markets: Ovarian Cancer – Pipeline Review, H1 2012

Research and Markets has announced the addition of Global Markets Direct's new report "Ovarian Cancer – Pipeline